CAI Caris Life Sciences, Inc.: institutional ownership and insider trading
272 funds reported holding $2.82B of Caris Life Sciences, Inc. in their latest 13F filings; in Q2 2026 funds net sold $39.1M, with 68 new positions and 24 funds selling out; over the last 12 months insiders bought $1.60M and sold $28.9M on the open market; over its last four quarters it reported revenue of $990M and net income of $105M.
CAI revenue and earnings
- Quarter ended Jun 30, 2026: revenue $264M, net income −$637K, EPS 0.00
- Quarter ended Mar 31, 2026: revenue $216M, net income −$510K, EPS 0.00
- Quarter ended Dec 31, 2025: revenue $293M, net income $82.0M, EPS 8.24
- Quarter ended Sep 30, 2025: revenue $217M, net income $24.3M, EPS 0.08
Famous investors holding CAI
- Stanley Druckenmiller (Duquesne Family Office): $33.8M, 0.7% of the portfolio
- Philippe Laffont (Coatue Management): $175M, 0.4% of the portfolio
- Izzy Englander (Millennium Management): $39.3M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $10.1M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $7.03M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $3.65M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $640K, 0.0% of the portfolio
Largest institutional holders of CAI
- FMR LLC — $551M
- J. H. Whitney Equity Partners VI, LLC — $201M
- COATUE MANAGEMENT LLC — $175M
- BRAIDWELL LP — $147M
- Sixth Street Partners Management Company, L.P. — $131M
- PointState Capital LP — $122M
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $120M
- BlackRock, Inc. (BLK) — $98.7M
- T. Rowe Price Investment Management, Inc. — $90.5M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $86.3M
Recent CAI insider trades
- Sep 22, 2026: Denton John Russel sold 7,500 shares ($239K)
- Sep 17, 2026: Brille Brian J sold 400,000 shares ($12.1M)
- Sep 4, 2026: Spetzler David Baxley sold 597,212 shares ($14.8M)
- May 15, 2026: Halbert Jon bought 68,000 shares ($990K)
5%+ owners
- FMR LLC: 10.8% (Schedule 13G/A, filed Apr 7, 2026)
Who owns the most CAI stock?
The largest institutional holders of Caris Life Sciences, Inc. in the latest 13F filings are FMR LLC ($551M), J. H. Whitney Equity Partners VI, LLC ($201M), COATUE MANAGEMENT LLC ($175M).
Are insiders buying or selling CAI?
Over the last 12 months insiders bought $1.60M and sold $28.9M of Caris Life Sciences, Inc. stock on the open market (SEC Form 4).
Which famous investors own CAI?
Stanley Druckenmiller, Philippe Laffont, Izzy Englander, Renaissance Technologies, Ken Griffin.
What was CAI's revenue last quarter?
Caris Life Sciences, Inc. reported revenue of $264M for the quarter ended June 30, 2026, with net income of −$637K.
Which ETFs hold CAI?
31 ETFs and mutual funds hold it among their top 100 positions, including FHCLX, HLGEX, FSMEX, XFBRX.